Arts & Opinion.com
  Arts Culture Analysis  
Vol. 15, No. 3, 2016
 
     
 
  Current Issue  
  Back Issues  
  About  
 
 
  Submissions  
  Subscribe  
  Comments  
  Letters  
  Contact  
  Jobs  
  Ads  
  Links  
 
 
  Editor
Robert J. Lewis
 
  Senior Editor
Bernard Dubé
 
  Contributing Editors
David Solway
Nancy Snipper
Louis René Beres
Nick Catalano
Lynda Renée
Jordan Adler
Andrew Hlavacek
Daniel Charchuk
Farzana Hassan
Betsy L. Chunko
Samuel Burd
Andrée Lafontaine
 
  Music Editors
Nancy Snipper
Serge Gamache
 
  Arts Editor
Lydia Schrufer
 
  Graphics
Mady Bourdage
 
  Photographer
Chantal Levesque Denis Beaumont
 
  Webmaster
Emanuel Pordes
 
 
 
  Past Contributors
 
  Noam Chomsky
Mark Kingwell
Naomi Klein
Arundhati Roy
Evelyn Lau
Stephen Lewis
Robert Fisk
Margaret Somerville
Mona Eltahawy
Michael Moore
Julius Grey
Irshad Manji
Richard Rodriguez
Navi Pillay
Ernesto Zedillo
Pico Iyer
Edward Said
Jean Baudrillard
Bill Moyers
Barbara Ehrenreich
Leon Wieseltier
Nayan Chanda
Charles Lewis
John Lavery
Tariq Ali
Michael Albert
Rochelle Gurstein
Alex Waterhouse-Hayward
 
     

satire
THE ZIKA VIRUS: BIG MONEYMAKER FOR BIG PHARMA


by
GARY OLSON

_________________________________________________________________

Gary Olson is a member of the Political Science Department at Moravian College in Bethlehem, PA.

 

[Note: The World Health Organization has declared the Zika virus an international public health emergency and some four million people may be infected this year. Zika may cause brain damage and unusually small heads in newborns—called microcephaly. Women who become infected while pregnant are at especially high risk.]

Uppyurs Pharmaceuticals, the drug manufacturing behemoth, is frantically attempting to vanquish rivals Novartis, Pfizer, GlaxoSmithKline and others by producing a Zika vaccine. A copy of the minutes from a recent Uppyurs Executive Board meeting was surreptitiously obtained by the author.

According to the minutes, “If everything breaks right we will have a Zika vaccine on the market by mid-2018 and we anticipate revenues in the range of $7.5 billion dollars. Proceeding with this is a no-brainer.”

The report also reveals that $78.00 for a single Zika inoculation will price the vaccine out of reach for all but the wealthy in the world’s 35 poorest countries. One of our serious challenges is to neutralize a guilt-ridden American public’s demand to make the vaccine more accessible or even—God help us—free to poor people. Our strategy includes:

• Because Americans are almost pathologically compassionate, we’ve been working on an empathy-inhibitor medication under the brand name ClearSoul. We can report that ClearSoul has been clinically tested on Uppyurs’s upper level management and has proven 100% effective. ClearSoul promises to be the most lucrative product in Uppyurs’s history, if not the history of the world. We saw a need and filled it. ClearSoul will be timed for market release just as Zika is declared a pandemic.

• Massive lobbying of Senate Foreign Relations Committee members so any government attempting to develop an inexpensive, generic version of the vaccine will be immediately accused of aiding and abetting global terrorism and be targeted by the U.S. drone attacks. We anticipate this will be an easy sell to the media and the public.

• As a distraction and to lighten the mood, we’ll prepare a series of small-headed baby jokes such as, “Why will Brazil’s soccer teams fail to make the World Cup after 2028? They’ll be unable to head the ball.”

• Friendly media sources have agreed to “tell Uppyurs’s story,” an inspiring narrative we’ve ghost written and which recommends that a Nobel Prize for Selfless Giving be created and bestowed upon Uppyurs Corporation. As a PR move, we’ll donate the Nobel Prize cash award of $1.5 million to the “Tiny Hoodies for Zika Victims” campaign and emblazon them with the Red, White and Blue Uppyurs logo.

• Candidly acknowledging the fact that immunizations in underdeveloped countries now cost nearly 70 times as much as they did in 2001, but that’s only because of supply and demand. Not enough poor people have died off, but that should change soon.

• When questioned about lowering costs for the Zika vaccine, our standard mantra is that we need to pay huge legal fees for patenting the manufacturing process, and who could deny the fairness of $25 million dollar bonuses for each member of our board of directors?

• Regrettably, governments of these desperately poor countries can only afford one vaccination program, including but not limited to Zika, whooping cough, TB, cholera, Ebola, Nipah virus, malaria, hepatitis B and D, HIV/AIDS and dengue fever. Given the immense profit margins for us, we’ve already bribed most public health ministers to choose Zika. The others will be banished from office by inventive, high profile sex and corruption scandals.

• Our invariable response to all criticism will be: Maximizing shareholder profits would be an egregious violation of our God-given, fiduciary trust. Anything less would be both Un-American and socialist.

• Finally, we’re working on an exciting new marketing slogan, tentatively titled:
Uppyurs: Making the World Healthier for Those of Us Who Really Matter.

This meeting is adjourned and, as always, “God Bless America and God Bless Uppyurs.”

Also by Gary Olson:
Cultivating Empathy
On the Birth of ISIS
Can Capitalism Save Itself
Manufacturing Memory
Unmaking War, Remaking Man
Rifkin and Singer

 

 

YOUR COMMENTS
Email (optional)
Author or Title

 

 

 

 

 

 

 

 

 

 

 

Arts & Opinion, a bi-monthly, is archived in the Library and Archives Canada.
ISSN 1718-2034

 

Help Haiti
Film Ratings at Arts & Opinion - Montreal
2015 Festival Nouveau Cinema de Montreal, Oct. 07-18st, (514) 844-2172
Montreal World Film Festival
Lynda Renée: Chroniques Québécois - Blog
Andrew Hlavacek - Arts & Culture Blog (Montreal)
© Roberto Romei Rotondo
Montreal Guitar Show July 2-4th (Sylvain Luc etc.). border=
2013 Montreal Chamber Music Festival
Photo by David Lieber: davidliebersblog.blogspot.com
SPECIAL PROMOTION: ads@artsandopinion.com
SUPPORT THE ARTS
Valid HTML 4.01!
Privacy Statement Contact Info
Copyright 2002 Robert J. Lewis